Skip Navigation


NDT Advance Access originally published online on October 27, 2007
Nephrology Dialysis Transplantation 2008 23(1):65-71; doi:10.1093/ndt/gfm475
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/1/65    most recent
gfm475v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schmidt, S.
Right arrow Articles by van der Giet, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, S.
Right arrow Articles by van der Giet, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org



The uraemic toxin phenylacetic acid increases the formation of reactive oxygen species in vascular smooth muscle cells

Sven Schmidt, Timm H. Westhoff, Phillip Krauser, Walter Zidek and Markus van der Giet

Medizinische Klinik IV – Nephrology, Charité Campus Benjamin Franklin, Berlin, Germany

Correspondence to: Dr Med. Sven Schmidt, Charité, Campus Benjamin Franklin, Medizinische Klinik IV, Nephrology, Hindenburgdamm 30, 12200 Berlin. Email: s.schmidt{at}charite.de



  Abstract

Background. Cardiovascular events are the most common cause of death in end-stage renal disease (ESRD) patients. Traditional risk factors do not sufficiently explain the marked increment in cardiovascular morbidity and mortality as compared with the general population. The role of uraemic toxins in the genesis of atherosclerosis remains elusive. Reactive oxygen species (ROS) play a major role in the development of atherosclerosis. In the present study, we describe the effect of the uraemic toxin phenylacetic acid (PAA) on the inducible nitric oxide synthase (iNOS) and the consecutive production of ROS.

Methods. Vascular smooth muscle cells (VSMC) were stimulated by IL-1β in the absence and presence of different concentrations of PAA (0.1–5.0 mM). Inducible NOS (iNOS) mRNA was determined by real-time PCR, iNOS protein was examined by western blotting. The NO degradation product, nitrite, was measured by Griess-assay and peroxynitrite (ONOO) was assessed by hydroethidium, 2',7'-dichlorodihydro-fluorescein diacetate (H2DCFDA) fluorescence assays. To evaluate the iNOS cofactor tetrahydrobiopterin (BH4), the expression of the key enzyme GTP cyclohydrolase (GTPCH) was determined by real-time PCR.

Results. PAA enhanced the IL-1β-mediated induction of iNOS expression regarding both mRNA and protein. Nitrite was significantly increased only with high concentrations of 5 mM PAA. ONOO, however, was enhanced in a dose-dependent manner. GTPCH, the key enzyme in BH4 synthesis, was not enhanced by PAA.

Conclusions. The uraemic toxin, PAA, leads to an induction of iNOS expression, resulting in an increase of ONOO production. The increased production of ONOO might be explained by a lack of GTPCH-catalysed BH4 synthesis leading to an uncoupled electron transfer. Thus, PAA might contribute to the oxidative stress in ESRD patients.

Keywords: atherosclerosis; end-stage renal disease; iNOS; peroxynitrite; phenylacetic acid; uraemic toxin

Received for publication: 12. 2.07
Accepted in revised form: 22. 6.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.